| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2010 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Vanguard Mega Cap Growth | 43 | Q2 2024 | 10.6% |
| Visa Inc | 43 | Q2 2024 | 10.4% |
| Vanguard FTSE All-World ex-US | 43 | Q2 2024 | 9.2% |
| Vanguard Growth | 43 | Q2 2024 | 5.9% |
| ISHARES TRUST TRS FLT RT BD ET | 43 | Q2 2024 | 4.8% |
| iShares S&P Small-Cap 600 Grow | 43 | Q2 2024 | 3.4% |
| Spdr S&P Biotech Etf | 43 | Q2 2024 | 3.3% |
| General Electric Co | 43 | Q2 2024 | 2.4% |
| WESCO International Inc | 43 | Q2 2024 | 1.2% |
| Target Corp | 43 | Q2 2024 | 1.3% |
View Blue Edge Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-07 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-21 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-10 |
View Blue Edge Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.